Post by Dr. Andreas Uttenweiler, MBA

Creating value for company, patients & society. Content/views are personal and do not necessarily represent those of my employer.

After Eli Lilly and Boehringer Ingelheim, now Roche and Pfizer review their future investment strategy in Germany due to planned cost saving policy. https://lnkd.in/em-XrfJH

Post content